CN104328210B - Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 - Google Patents
Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 Download PDFInfo
- Publication number
- CN104328210B CN104328210B CN201410682428.9A CN201410682428A CN104328210B CN 104328210 B CN104328210 B CN 104328210B CN 201410682428 A CN201410682428 A CN 201410682428A CN 104328210 B CN104328210 B CN 104328210B
- Authority
- CN
- China
- Prior art keywords
- primer
- aml1
- test kit
- seqidno
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000012360 testing method Methods 0.000 title claims abstract description 25
- 101000719121 Arabidopsis thaliana Protein MEI2-like 1 Proteins 0.000 title claims abstract description 24
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 title claims abstract description 24
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 title claims abstract description 24
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 18
- 238000007397 LAMP assay Methods 0.000 title claims abstract description 17
- 230000004927 fusion Effects 0.000 title claims abstract description 15
- 102100024952 Protein CBFA2T1 Human genes 0.000 claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims description 31
- 239000000376 reactant Substances 0.000 claims description 22
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 239000013641 positive control Substances 0.000 claims description 13
- 239000013642 negative control Substances 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960002378 oftasceine Drugs 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 102100034343 Integrase Human genes 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 16
- 208000007660 Residual Neoplasm Diseases 0.000 abstract description 15
- 208000032839 leukemia Diseases 0.000 abstract description 10
- 230000035945 sensitivity Effects 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000003321 amplification Effects 0.000 abstract description 5
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 5
- 230000000007 visual effect Effects 0.000 abstract description 5
- 206010000830 Acute leukaemia Diseases 0.000 abstract description 4
- 230000004544 DNA amplification Effects 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 238000007689 inspection Methods 0.000 abstract description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 7
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000036762 Acute promyelocytic leukaemia Diseases 0.000 description 3
- 208000033826 Promyelocytic Acute Leukemia Diseases 0.000 description 3
- 208000026784 acute myeloblastic leukemia with maturation Diseases 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001437 manganese ion Inorganic materials 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 101100389786 Arabidopsis thaliana ETO1 gene Proteins 0.000 description 1
- 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000009033 hematopoietic malignancy Effects 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 101150044508 key gene Proteins 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410682428.9A CN104328210B (zh) | 2014-11-24 | 2014-11-24 | Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410682428.9A CN104328210B (zh) | 2014-11-24 | 2014-11-24 | Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104328210A CN104328210A (zh) | 2015-02-04 |
CN104328210B true CN104328210B (zh) | 2016-06-22 |
Family
ID=52403015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410682428.9A Expired - Fee Related CN104328210B (zh) | 2014-11-24 | 2014-11-24 | Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104328210B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105483253A (zh) * | 2015-12-30 | 2016-04-13 | 广州安必平医药科技股份有限公司 | Aml1基因和eto基因检测探针及其制备方法和试剂盒 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102251031A (zh) * | 2011-06-30 | 2011-11-23 | 北京思尔成生物技术有限公司 | 白血病融合基因的TaqMan-MGB探针实时荧光PCR检测方法及其专用引物、探针与试剂盒 |
CN102827937A (zh) * | 2012-09-06 | 2012-12-19 | 上海源奇生物医药科技有限公司 | 一种检测白血病相关融合基因的引物和探针、及其试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090136942A1 (en) * | 2007-09-18 | 2009-05-28 | Oncomedx, Inc. | Analysis of Extracellular RNA |
-
2014
- 2014-11-24 CN CN201410682428.9A patent/CN104328210B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102251031A (zh) * | 2011-06-30 | 2011-11-23 | 北京思尔成生物技术有限公司 | 白血病融合基因的TaqMan-MGB探针实时荧光PCR检测方法及其专用引物、探针与试剂盒 |
CN102827937A (zh) * | 2012-09-06 | 2012-12-19 | 上海源奇生物医药科技有限公司 | 一种检测白血病相关融合基因的引物和探针、及其试剂盒 |
Non-Patent Citations (1)
Title |
---|
DiaSorin QLAMP Amplification Technology Coupled with Liaison Iam Instrument as a Rapid and Reliable Diagnostic System for Detection of Molecular Markers Associated to Leukemias;Amicarelli G, et al;《Journal of Molecular Diagnostics》;20131231;第15卷(第6期);867-867 * |
Also Published As
Publication number | Publication date |
---|---|
CN104328210A (zh) | 2015-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Label-free and ultrasensitive fluorescence detection of cocaine based on a strategy that utilizes DNA-templated silver nanoclusters and the nicking endonuclease-assisted signal amplification method | |
CN112239795A (zh) | 基于rt-rpa和crispr的可视化新冠病毒rna核酸检测试剂盒 | |
US11104948B2 (en) | NGS systems control and methods involving the same | |
CN111534514A (zh) | 一种基于Crisper的新型冠状病毒的检测试剂盒 | |
Chi et al. | CRISPR-Cas14a-integrated strand displacement amplification for rapid and isothermal detection of cholangiocarcinoma associated circulating microRNAs | |
WO2023025259A1 (zh) | 检测微小rna的方法和试剂盒 | |
CN112195278A (zh) | 一种六项呼吸道病毒核酸检测试剂盒及使用方法 | |
Chen et al. | A universal platform for one-pot detection of circulating non-coding RNA combining CRISPR-Cas12a and branched rolling circle amplification | |
Gou et al. | The colorimetric isothermal multiple-self-matching-initiated amplification using cresol red for rapid and sensitive detection of porcine circovirus 3 | |
CN107287320A (zh) | Gapdh基因的lamp检测用引物组合及试剂盒 | |
CN104328209B (zh) | 白血病微小残留病wt1基因快速检测方法的引物和试剂盒 | |
CN104328210B (zh) | Aml1/eto融合基因的环介导等温扩增检测方法的引物和试剂盒 | |
CN103103259A (zh) | 确定核酸样本的两个预定位点是否具有已知突变的方法、试剂盒以及引物 | |
CN105039598A (zh) | 一种中东呼吸综合征冠状病毒ORF1a2基因检测试剂盒 | |
CN107641649B (zh) | 检测微卫星nr27位点稳定性的引物对、试剂盒及方法 | |
CN106086226A (zh) | 一种与IgA肾病辅助诊断相关的血浆miRNA标志物及其应用 | |
CN104328211B (zh) | PML-RARα融合基因的环介导等温扩增检测方法的引物和试剂盒 | |
CN104278024B (zh) | 用于鉴定人类腺病毒55型的引物组合物以及它们的应用 | |
CN113025619B (zh) | 一种hook3-fgfr1新融合基因及其应用和检测试剂盒 | |
CN105567867B (zh) | 人类免疫缺陷病毒1型实时荧光核酸恒温扩增检测试剂盒 | |
CN114250311A (zh) | 一种检测斑点热群立克次体的cda引物组、试剂盒及其应用 | |
CN108165633B (zh) | 一种特异性阻抑引物体系及肿瘤ct-DNA突变检测的方法 | |
CN104328213B (zh) | Bcr-abl融合基因快速检测方法的引物和试剂盒 | |
Wang et al. | Digital detection of T790M—yes or no to an ultrasensitive assay | |
CN220056885U (zh) | 一种检测毛霉菌的多重液滴数字pcr试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210531 Address after: Room 1309, building 3, Dongdu International Plaza, 88 Gongye North Road, Licheng District, Jinan City, Shandong Province, 250132 Patentee after: Shandong ShuoKe Biotechnology Co.,Ltd. Patentee after: BEIJING LANPU BIOTECHNOLOGY DEVELOPMENT Co.,Ltd. Address before: No.18877, Jingshi Road, Lixia District, Jinan City, Shandong Province, 250062 Patentee before: INSTITUTE OF BASIC MEDICINE, SAMS Patentee before: BEIJING LANPU BIOTECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160622 |